S-equol status modulates skin response to soy isoflavones in postmenopausal women: results from a randomized placebo-controlled pilot trial
Frontiers in Nutrition · 03.11.2025 · 12
DOI: 10.3389/fnut.2025.1671835 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 03.11.2025. Verfasst von Vineetha Vijayakumar und 7 weiteren Autor:innen. Beteiligte Einrichtung: ADM R&D Medical, ADM Health & Wellness, London, United Kingdom. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/objectives Soy isoflavones may benefit skin health in postmenopausal women, potentially via S-equol, a gut-derived metabolite with enhanced estrogenic and antioxidant activity.
Methods
Sixty-six postmenopausal women received either Novasoy®400 ( n = 33), a soy isoflavone extract, or identical placebo ( n = 33) for 12 weeks. Skin parameters, including crow’s feet and under-eye wrinkles, hydration, barrier function, and skin colour were assessed at baseline, D42 and D84. Urinary isoflavone metabolites, including S-equol, were measured at each time point.
Results
Crow’s feet wrinkle roughness decreased by 5.6% in the Novasoy®400 group versus a 1.6% increase in the placebo group, this difference was not statistically significant. However, urinary biomarker analysis identified 46.9% of women in the Novasoy®400 group and 15.6% in the placebo group as S-equol producers. In exploratory regression analysis limited to S-equol producers, higher urinary S-equol levels were significantly associated with improved under-eye wrinkle parameters and transepidermal water loss (TEWL) at D42. Multivariable model adjusting for age, soy intake, phototype and their interactions confirmed that older women experienced greater improvements in undereye wrinkles and barrier function in response to increased S-equol levels. Skin hydration showed a modest but statistically significant association with S-equol when combining data from both D42&84, indicating a potential cumulative effect.
Conclusion
Soy isoflavone supplementation increased urinary S-equol concentrations and was associated with improvements in under-eye wrinkle appearance, skin hydration, and barrier function—particularly among older postmenopausal women identified as S-equol producers. Findings suggest region-specific, time-sensitive effects dependent on S-equol levels. Clinical trial registration https://clinicaltrials.gov/study/NCT06047145 , NCT06047145.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ADM R&D Medical, ADM Health & Wellness, London, United Kingdom.
- ADM R&D Center-Valencia, ADM Health & Wellness, Parc Científic Universitat de València, Valencia, Spain.
Zitieren
APA
Vijayakumar, V., Climent, E., Enrique, M., Lamelas, A., Álvarez, B., Chenoll, E., Naghibi, M., & Day, R. (2025). S-equol status modulates skin response to soy isoflavones in postmenopausal women: results from a randomized placebo-controlled pilot trial. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1671835
Vancouver
Vijayakumar V, Climent E, Enrique M, Lamelas A, Álvarez B, Chenoll E, et al. S-equol status modulates skin response to soy isoflavones in postmenopausal women: results from a randomized placebo-controlled pilot trial. Frontiers in Nutrition. 2025;12. doi:10.3389/fnut.2025.1671835
BibTeX
@article{Vijayakumar2025,
author = {Vijayakumar, Vineetha and Climent, Eric and Enrique, María and Lamelas, Araceli and Álvarez, Beatriz and Chenoll, Empar and Naghibi, Malwina and Day, Richard},
title = {S-equol status modulates skin response to soy isoflavones in postmenopausal women: results from a randomized placebo-controlled pilot trial},
journal = {Frontiers in Nutrition},
year = {2025},
volume = {12},
doi = {10.3389/fnut.2025.1671835}
}
EUVIMED